Thus, inhibiting inflammatory response to reduce the production of cytokines such as G-CSF and IL-6, or blocking the ligands for TLR2/4, when the increased CTC counts is detected, might be very important for designing the therapeutic strategy to prevent tumor metastasis. Here, IL6 is linked to neoplasm.